We recommend Durataz instead of Tazopiper. Exact salt composition from top brand
100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothPiperacillin 2000mg + Tazobactum 250mg
Salt CompositionPiperacillin 2000mg + Tazobactum 250mg (same for both)
Tazopiper 2000mg/250mg Injection
You Searched
Tazopiper 2000mg/250mg Injection
Zoic Lifesciences
Tazopiper 2000mg/250mg Injection
Zoic Lifesciences
₹260
Our Recommendation
Durataz 2000/250mg Injection 20ml
Aristo Pharmaceuticals Pvt. Ltd.
494+ Customers trust this
WHO GMP Certified
Assured by
Assured
Durataz 2000/250mg Injection 20ml
Assured by
Assured
494+ trust this
WHO GMP Certified
Customers also bought
More About Tazopiper
Benefits
In Bacterial infections : Tazopiper 2000mg/250mg Injection contains two different medicines that work together to kill the bacteria that cause infections. Piperacillin belongs to a group of medicines called penicillins that work by stopping the growth of bacteria. Tazobactam is a beta-lactamase inhibitor that reduces resistance and enhances the activity of Piperacillin against bacteria.Tazopiper 2000mg/250mg Injection can be used to treat many different bacterial infections such as ear, sinus, throat, lung, urinary tract, skin, teeth, joints, and bones. This medicine usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.
Side Effects
Side effects of Tazopiper Injection The majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Tazopiper Nausea Vomiting Diarrhea Rash Allergic reaction
How to use
How to use Tazopiper Injection Your doctor or nurse will give you this medicine. Kindly do not self administer.
How it works
How Tazopiper Injection works Tazopiper 2000mg/250mg Injection is a combination of two medicines: Piperacillin and Tazobactum. Piperacillin is an antibiotic. It works by preventing the formation of the bacterial protective covering which is essential for the survival of bacteria. Tazobactum is a beta-lactamase inhibitor which reduces resistance and enhances the activity of Piperacillin against bacteria.
Safe: No harmful side effects are associated with consuming alcohol alongside Tazopiper 2000mg/250mg Injection
Tazopiper 2000mg/250mg Injection is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Tazopiper 2000mg/250mg Injection is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
It is not known whether Tazopiper 2000mg/250mg Injection alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Tazopiper 2000mg/250mg Injection should be used with caution in patients with kidney disease. Dose adjustment of Tazopiper 2000mg/250mg Injection may be needed. Doctor consultation is advised.
Tazopiper 2000mg/250mg Injection is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Tazopiper 2000mg/250mg Injection may not be needed in these patients. Please consult your doctor.
What if I forget to take it?
If a dose of Tazopiper 2000mg/250mg Injection is missed, it's advisable to consult your doctor.
Manufacturer Address
72/1, Tyagi Road, Dehradun (Uttarakhand)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
